1. Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
   Virginia Albiñana et al, 2022, Journal of Clinical Medicine CrossRef
2. The role of ADRB2 gene polymorphisms in malignancies
   Yaqian Wang et al, 2021, Molecular Biology Reports CrossRef
3. The Relationship Between Anti-Hypertensive Drugs and Cancer: Anxiety to be Resolved in Urgent
   Rong Yang et al, 2020, Frontiers in Pharmacology CrossRef
4. Trial watch: beta-blockers in cancer therapy
   Killian Carnet Le Provost et al, 2023, OncoImmunology CrossRef
5. Identify potential miRNA-mRNA regulatory networks contributing to high-risk neuroblastoma
   Feng-Ling Shao et al, 2021, Investigational New Drugs CrossRef
6. Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
   Rachel Massalee et al, 2024, Frontiers in Pharmacology CrossRef
7. Screening and Identification of Key Common and Specific Genes and Their Prognostic Roles in Different Molecular Subtypes of Breast Cancer
   Na Sun et al, 2021, Frontiers in Molecular Biosciences CrossRef
8. The Potent Cytotoxic and Oxidative Effects of β-2 Selective ICI-118,551 on Breast Adenocarcinoma Cell Lines with Different Aggressiveness
   Berna KAVAKCIOĞLU YARDIMCI, 2021, Clinical and Experimental Health Sciences CrossRef
9. Drug Repurposing for Triple-Negative Breast Cancer
   Marta Ávalos-Moreno et al, 2020, Journal of Personalized Medicine CrossRef
10. 10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling
    Yuqi Liang et al, 2023, Drug Design, Development and Therapy CrossRef
11. Genetic polymorphisms are associated with individual susceptibility to dexmedetomidine
    Yuanyuan Ding et al, 2023, Frontiers in Genetics CrossRef